None listed
Conditions
Brief summary
This project tests whether a structured medicines reconciliation service (DCMedsRec) delivered by a community pharmacy soon after hospital discharge may reduce the risk of re-admission within 30 days. This randomised controlled trial will compare the rates of readmission of those receiving the DCMedsRec with others receiving usual care after discharge. Participants receiving the DCMedsRec service will have a structured interview with a pharmacist in a community pharmacy where, using My health record and other sources, the correct medicines and doses will be identified, old medicines and prescriptions may be disposed of, understanding of when and how to take medicines may be confirmed and any questions be answered. It is expected that DCMedsRec will improve medicines use and adherence and reduce the risk of problems that lead to re-admission.
Interventions
The DCMedsRec intervention involves the delivery of a structured medicines reconciliation service in a community pharmacy within a week of hospital discharge. The participant will have a medicines reconciliation interview with a community pharmacist who will use the participants MyHealthRecord discharge summary as the basis for the reconciliation to consolidate medicines knowledge and use, dispose of unwanted medicines and prescriptions and use health literacy principles to enhance medicines un
The DCMedsRec intervention involves the delivery of a structured medicines reconciliation service in a community pharmacy within a week of hospital discharge. The participant will have a medicines reconciliation interview with a community pharmacist who will use the participants MyHealthRecord discharge summary as the basis for the reconciliation to consolidate medicines knowledge and use, dispose of unwanted medicines and prescriptions and use health literacy principles to enhance medicines understanding and adherence to recommended use. This will be done face to face, one on one, in the community pharmacy of the participants selection and is expected take approximately 20 minutes (maybe up to 30 minutes if on large number of medicines). Approved medicines information resources (print and electronic) may be used in this process. The community pharmacist will deliver the intervention. The outcome of 30-day unplanned readmission will be the primary outcome of adherence and patients may have ongoing interaction with their pharmacist as in the normal course of their healthcare. There are no other specific strategies to assess or monitor adherence. Fidelity to the intervention will be monitored by completion of the checklist of specific activities for the service on the submitted payment claim form from the pharmacy.
Sponsors
Eastern Health
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Blinded (masking used) (Subject, Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
All patients discharged from trial hospital with 4 or more medications at discharge Residential postcode in trial hospital network catchment area
Exclusion criteria
Patients with emergency department visits only (not admitted to a ward) Patients admitted to short stay units Discharge to nursing home, another hospital or other institutional setting Discharge with 3 or less prescription items Residential postcode outside EH network catchment district Under 18 years of age
Outcome results
None listed